Mary Babb Randolph Cancer Center

Name :

Mary Babb Randolph Cancer Center

Address  :

One Medical Center Drive
PO Box 8110

Town  :

Morgantown

State  :

West Virginia

Country  :

USA

Post Code:

26506 8110

Phone  :

304 293 4500

Web URL  :


Description

About Us
The Mary Babb Randolph Cancer Center is West Virginias premier cancer facility with a national reputation of excellence in cancer treatment prevention and research

Located in Morgantown within the West Virginia University School of Medicine MBRCC is recognized by the American College of Surgeons Commission on Cancer for providing the best in cancer care Our multidisciplinary team of physicians researchers and other healthcare experts work together to develop and implement the best possible individualized treatment plans which include standard treatments and exciting alternatives offered through clinical trials

Through the MBRCC Molecular Medicine Core Facility we are identifying genetic markers that are associated with specific cancers and patients reactions to cancer drugs that will allow physicians and pharmacists to tailor a cancer treatment to a patients genetic pattern In our stateoftheart proteomics lab basic science researchers are studying cancer at the molecular level and translating their findings into potentially useful drugs and treatments

The MBRCC leads several federallyfunded programs designed to translate research findings into education programs and training for healthcare providers and the public The National Cancer Institute NCI chose WVUs Cancer Center to locate its MidAtlantic Cancer Information Service office
The Mount Sinai Hospital Experts Debunk the 5 Most Common Postpartum Depression Myths Plaguing Latin

According to a recent study more than 30 of Latinas in the US and Mexico suffer perinatal or postpartum depression making it the number one complication of pregnancy among Latinas In an effort to raise visibility for a disease that is often dismissed physicians from The Mount Sinai Hospital debunked the 5 most prevalent Latino myths about postpart... Read More

Group B Neisseria meningitidis Vaccine Shows Promise

An investigational vaccine may represent a strong lead in the fight against group B Neisseria meningitidis according to results of a phase 2 study published online in the Lancet Administered in 3 doses over the course of 6 months a new bivalent vaccine was well tolerated and induced a strong immune response against multiple strains of the poten... Read More